Multiple Sclerosis Clinical Trials in Phoenix

Showing 161-180 of 268 trials

Pivotal Study of the FRED Stent System in the Treatment of Intracranial Aneurysms

NCT01801007

The purpose of this study is to evaluate the safety and effectiveness of the MicroVention Flow Redirection Intraluminal Device (FRED) system when used in the treatment of wide-necked intracranial aneurysms.

Intracranial Aneurysms

Microvention-Terumo, Inc.145 participantsStarted Jul 2013

Phoenix, Arizona, United States • Englewood, Colorado, United States • Jacksonville, Florida, United States +21 more locations

COMPLETED< 1 mile

Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens

NCT02267876

The purpose of the study is to assess the cumulative disease detection of greater than or equal to Cervical intraepithelial neoplasia 2 (CIN2) and greater than or equal to Cervical intraepithelial neoplasia 3 (CIN3) in the subjects over 3 years using the subject's HPV status and cytology status from the BDS-USHPV baseline results

Cervical NeoplasmsHuman Papillomavirus

Becton, Dickinson and Company6,730 participantsStarted Oct 2014

Birmingham, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +37 more locations

Pivotal Study of the FRED Stent System in the Treatment of Intracranial Aneurysms

Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens

Multiple Sclerosis Trials in Other Cities

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer

An Open Label Study of Oral Enzastaurin in Participants With Cancer

ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

National Marrow Donor Program Long-Term Donor Follow-Up

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung

Study of Personalized Immunotherapy in Adults With Metastatic Colorectal Cancer

Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228

Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer

A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)

A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma

Other Conditions in Phoenix